All News

Researchers evaluated the efficacy of a self-managed intervention vs enhanced usual care.

Michael Ganio, PharmD, BCPS, FASHP, discusses how the industry can become more resilient.

Researchers analyzed the impact of the COVID-19 pandemic on outcomes for patients with pancreatic cancer living in England.

Drug Topics sat down with Adam J. James, PharmD, to discuss his journey from chain pharmacist to innovation leader at Rite Aid."

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, also discusses ways community pharmacists can collaborate with other healthcare professionals to enhance diabetes management.

A conversation with Trent Thiede, PharmD, MBA, president of PAAS National, at NCPA 2024.

A conversation with Michael Ganio, PharmD, BCPS, FASHP, senior director of Pharmacy Practice and Quality at ASHP.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses how pharmacists can help with diabetes prevention and early detection in the community.

Pharmacy experts from AON Pharmacy in Florida discussed the Inflation Reduction Act and how it affects reimbursement for Medicare Part D drugs.

Cassandra Esperant, PharmD, AAHIVP, discussed the ups and downs of her career journey as a clinical HIV pharmacist.

A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.

Researchers compared the racial and ethnic representation of participants in food allergen trials with patients who experience food allergies.

Selina Coleman, JD, Partner in Life Sciences Health Industry Group at Reed Smith LLP, discussed recent developments in Supreme Court decisions impacting pharmacy operations.

The data from PURPOSE 2 will be published in The New England Journal of Medicine.

An FDA representative gave a presentation on her organization’s recent updates regarding drug supply chain rules and regulations.

A recent study found that with greater depression severity, metabolic and clinical characteristics such as HbA1c, fasting blood glucose, and triglyceride levels increased.

Pharmacy law experts detailed the Drug Supply Chain Security Act, highlighting the role each entity within the supply chain plays in ensuring the safety and authenticity of US prescription drugs.

High copayments can be a structural barrier to medication therapy adherence.

The agency assigned prademagene zamikeracel a PDUFA target action date of April 29, 2025.

FDA experts gathered to discuss the DEA’s rescheduling of marijuana and how it will impact the pharmaceutical supply chain.

Lauren Angelo, PharmD, MBA, discusses effective ways pharmacists can educate and encourage their communities on the importance of flu vaccination.

Research has found that children and young adults with overweight or obesity may be at a significantly increased risk of developing long COVID.

Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.

A new study found that individuals who received a COVID-19 vaccine more recently were less likely to develop long COVID.

Joel Ferre, JD, Assistant United States Attorney in Utah, led a discussion covering the DEA and pharmacies’ roles in reporting red flags when dispensing medication.

Check out these important FDA updates from the week of November 4.

Researchers attempted to understand the evolving epidemiology of gastrointestinal stromal tumors in major organ sites.

Melissa Durham, PharmD, MACM, reveals how pharmacists are uniquely positioned to counsel patients on nonopioid pain management.